Progenics Pharmaceuticals News

Sadly, there's no such thing as an ultimate buy signal when it comes to investing in stocks.

Evidence is mounting that morphine, commonly used to manage pain, may accelerate cancer growth, but a newly-approved drug that blocks its side effects could also keep tumors from spreading, U.S. researchers said on Wednesday.

Progenics Pharmaceuticals, Inc. announced its results of operations for the third quarter and nine months ended September 30, 2009.

BioMed Realty Trust, Inc. , a real estate investment trust focused on Providing Real Estate to the Life Science IndustryA , today announced operating and financial results for the third quarter ended September 30, 2009.

Last week's top five stocks that were bought by their CEOs were DSW Inc, Sunstone Hotel Investors Inc, Progenics Pharmaceuticals Inc, Acorn Energy Inc, and Mitcham Industries Inc.

Several small-cap stocks were poised to move on above-average volume during Wednesday's session.

Progenics Pharmaceuticals ' constipation reliever, Relistor, is a good drug that not enough people want.

On 10/14/09, Progenics Pharma announced a deal with Wyeth to re-acquire all of the worldwide rights to the RELISTOR franchise after a one-year transition period.

Progenics Pharmaceuticals, Inc. today announced that it has entered into an agreement with Wyeth Pharmaceuticals, a division of Wyeth under which Progenics is regaining all worldwide rights to the RELISTOR franchise from Wyeth Pharmaceuticals, which Progenics had previously licensed to Wyeth Pharmaceuticals.

HUMBLE, Texas-- --So Act Network, Inc. announced today that its social action network is iMac and iPhone compatible.

More than a dozen drugs including a cancer therapy and a bowel medicine are under early scrutiny for potential side effects, U.S. regulators said in a quarterly list released on Thursday.

AstraZeneca is drinking nectar, but it might be getting drunk off the stuff. After all, the company gave Nektar Therapeutics one sweet deal yesterday.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Progenics Pharmaceuticals, Inc. announced the promotion of Mark R. Baker to the newly created position of President.

PepsiCo Americas Beverages named Jill Beraud as its chief marketing officer and president-joint ventures.

PepsiCo Americas Beverages named Jill Beraud as its chief marketing officer and president-joint ventures.

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, August 6th and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and August earnings reports.

Additional FDA Calendar Updates For Dyax Corp. , Arena Pharma , And Progenics Pharma BioMedReports.Com has new updates to it's database of FDA Calendars Published on June 09, 2009 by BiomedReports.Com Staff LOS ANGELES, CA BioMedReports.Com, the news portal covering the biomedical sector that delivers financial and investment intelligence to a ...

NEEDHAM, Mass.-- --PTC , The Product Development Company , today launched Windchill RequirementsLink, the newest addition to its Windchill content and process management - GREENWOOD VILLAGE, Colo.-- --WildBlue Communications, a Colorado-based, satellite broadband Internet provider, is presenting its "next generation" satellite capabilities on ...

Jun 8, 2009 - Progenics Pharmaceuticals, Inc. today announced that its collaborator, Ono Pharmaceutical Co., Ltd., Osaka, Japan has begun clinical testing in Japan of RELISTOR subcutaneous injection, the first-in-class medicine approved in the U.S., Canada, the European Union, Australia and Latin American countries for the treatment of ...